EYENOVIA
Eyenovia is a biopharmaceutical company that provides portfolio of next generation topical eye treatments. It is a clinical stage, ophthalmic biopharmaceutical company that transforms the delivery of therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. Eyenovia’s breakthrough piezo-dispersion and microdosing technology enable a portfolio of first-in-class, next-generation, micro-therapeutics for the eye designed to reduce ocular and systemic toxicity and improve the risk-benefit profile of both new and existing therapeutics. Eyenovia was founded in 2014.
EYENOVIA
Industry:
Biotechnology Pharmaceutical
Founded:
2014-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.eyenovia.com
Total Employee:
11+
Status:
Active
Contact:
(917) 289-1117
Email Addresses:
[email protected]
Total Funding:
53.14 M USD
Technology used in webpage:
Amazon Amazon Route 53 Amazon Ohio Region
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Armistice Capital
Armistice Capital investment in Post-IPO Equity - Eyenovia
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Eyenovia
Key Employee Changes
Official Site Inspections
http://www.eyenovia.com Semrush global rank: 5.06 M Semrush visits lastest month: 1.63 K
- Host name: 45.184.227.35.bc.googleusercontent.com
- IP address: 35.227.184.45
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
